To ask the Secretary of State for Health and Social Care, if he will publish an updated timetable for the estimated (a) regulatory approval and (b) delivery to the NHS of the (i) Novavax and (ii) Johnson & Johnson covid-19 vaccines; and if he will make a statement.
This answer is the replacement for a previous holding answer.
26 March 2021
Reviews are underway by the Medicines and Healthcare products Regulatory Agency (MHRA) to assess the Johnson & Johnson (known by Janssen in Europe) and Novavax vaccines. Any vaccines that are made available will have been authorised because they pass the MHRA’s tests on safety and efficacy. If and when those vaccines are authorised by the MHRA, we expect to receive the doses for both vaccines in the second half of this year.